Pathology and Clinical Laboratory Medicine Risk Assessment: Specimen, Result and Safety Controls

This assessment shows how a hospital pathology laboratory can find, rate and control the risks that matter most to patient safety and to the reliability of test results. Eight hazards were chosen because they are plausible in everyday laboratory, clinical and information work. Specimen identification and critical result communication carry the highest potential harm, so they are scored Critical or High before controls. Each hazard is rated before controls and again after existing and added controls. Most fall to Medium or Low once controls are in place, but specimen misidentification stays High until labelling and verification are fully embedded. The first actions are a two identifier check at collection, a tested critical result pathway and a practised downtime procedure. The scores are teaching examples, and specialist review is needed for any real service.

Scope

This assessment covers a hospital pathology laboratory, from specimen collection and transport through testing, result release, storage and disposal. It looks at risks to patients, staff, results and confidential information. It does not cover individual diagnosis or treatment decisions. Jurisdiction, analyser models and staffing structure are assumptions made for teaching.

Context

The laboratory receives requests from inpatient wards, outpatient clinics and emergency departments. Samples are collected by clinical staff and transported to the laboratory, where automated analysers run haematology, chemistry and microbiology tests. Results are released through a laboratory information system and sent to clinicians electronically or by phone. A consultant pathologist oversees reporting, and the service is reviewed through internal and external quality processes. Each risk is scored before controls to show its natural level, then again after existing and added controls.

Objectives, assets and stakeholders

The objective is to deliver accurate, timely and safe test results, protect patients, staff and confidential information, and keep the service able to operate during disruption. The assets in scope are specimens, analysers, the laboratory information system, reagents and consumables, patient records, the laboratory premises and the professional reputation of the service. Stakeholders include patients and families, ward and clinic clinicians, laboratory scientists and technicians, the consultant pathologist, the information governance function, occupational health, suppliers and the clinical governance group. Each risk has one owner role, and the laboratory manager keeps the register current and reports to the clinical governance group each quarter.

Each hazard is rated on two five-point scales. Likelihood runs from Rare to Almost certain, and impact runs from Negligible to Catastrophic, with patient harm weighted most heavily. Multiplying the two gives a score from 1 to 25. Low runs from 1 to 4 and means accept and monitor. Medium runs from 5 to 9 and needs routine controls with a named owner. High runs from 10 to 16 and needs senior attention with a dated plan. Critical runs from 17 to 25 and needs immediate action and escalation to clinical leadership. Inherent risk is the score before any controls. Residual risk is the score after existing and added controls are in place, and it must never be higher than the inherent score. Risks that are not yet controlled are not rated down because they have not yet happened. Ratings are challenged by the staff who do the work, reviewed by the laboratory quality group, and re-scored whenever a monitoring threshold is reached or an incident occurs. Specialist review is needed before any score is used in a real service.

Contingency arrangements

If a serious event occurs, such as a wrong patient result, a lost specimen batch or a major analyser failure, the laboratory manager stops affected testing and secures records. The consultant pathologist reviews any result that may have caused harm and informs the treating clinician at once. The information systems lead switches to the downtime procedure and restores data from the latest tested backup. Infection prevention and occupational health are contacted for any exposure. Reagent stock moves to the agreed alternative supplier, and clinicians are told of any delay. Specialist review is needed before any clinical decision is changed.

Conclusion

Safe pathology depends on a few steady habits: two identifier checks at collection, a tested critical result route, a practised downtime plan, protected information and steady staffing with trained cover. The highest scores sit with specimen identity and critical result communication, and each has actions that reduce the residual score. Treat the register as a living record, review it on the stated cycle and refer any clinical, regulatory or legal question to a qualified pathologist or licensed professional.